Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 1
1986 4
1987 4
1988 4
1989 5
1990 3
1991 2
1992 5
1993 1
1994 3
1995 9
1996 2
1997 13
1998 9
1999 8
2000 9
2001 17
2002 12
2003 21
2004 22
2005 42
2006 38
2007 50
2008 64
2009 83
2010 104
2011 105
2012 116
2013 130
2014 157
2015 203
2016 169
2017 192
2018 238
2019 260
2020 330
2021 358
2022 404
2023 414
2024 472
2025 516
2026 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,113 results

Results by year

Filters applied: . Clear all
Page 1
Early detection of multiple cancer types using multidimensional cell-free DNA fragmentomics.
Bao H, Yang S, Chen X, Dong G, Mao Y, Wu S, Cheng X, Wu X, Tang W, Wu M, Tang S, Liang W, Wang Z, Yang L, Liu J, Wang T, Zhang B, Jiang K, Xu Q, Chen J, Huang H, Peng J, Xia X, Wu Y, Xu S, Tao J, Chong L, Zhu D, Yang R, Chang S, He P, Xu X, Zhang J, Shen Y, Jiang Y, Liu S, Zhang X, Wu X, Wang X, Shao Y. Bao H, et al. Among authors: dong g. Nat Med. 2025 Aug;31(8):2737-2745. doi: 10.1038/s41591-025-03735-2. Epub 2025 May 27. Nat Med. 2025. PMID: 40425843
2024 International Expert Consensus on US-guided Thermal Ablation for T1N0M0 Papillary Thyroid Cancer.
Zhao ZL, Wang SR, Kuo J, Çekiç B, Liang L, Ghazi HA, Xu SH, Amabile G, Wu SS, Yadav A, Dong G, Janssen I, Fan BQ, Fukunari N, He JF, Dung LT, Yu SY, Leong S, Yu JJ, Chou YH, De Cicco R, Che Y, Cheng KL, Kandil E, Lin WC, Xu D, Russell J, Lu M, Tufano RH, Qian LX, Randolph GW, Zhou JQ, Mauri G, Su HH, Russell M, Abdelhamid Ahmed AH, Patel K, Baek JH, Kim JH, Wei Y, Yu MA. Zhao ZL, et al. Among authors: dong g. Radiology. 2025 Apr;315(1):e240347. doi: 10.1148/radiol.240347. Radiology. 2025. PMID: 40261172 Review.
Ivarmacitinib, a selective Janus kinase 1 inhibitor, in patients with moderate-to-severe active rheumatoid arthritis and inadequate response to conventional synthetic DMARDs: results from a phase III randomised clinical trial.
Liu J, Jiang Y, Zhang S, Liu S, Su J, Lin C, He X, Wu R, Yang L, Liu H, Duan X, Xu S, Luo H, Liu J, Xie Q, Mi C, Chen L, Zhang N, Gong H, Zhu J, Li Y, Wei H, Qian L, Wang J, Shi X, Jin H, Jiang Z, Xie X, Zhan F, Geng X, Zheng Z, Du Z, Dong G, Sun Y, Zeng X. Liu J, et al. Among authors: dong g. Ann Rheum Dis. 2025 Feb;84(2):188-200. doi: 10.1136/ard-2024-226385. Epub 2025 Jan 3. Ann Rheum Dis. 2025. PMID: 39919893 Clinical Trial.
4,113 results